AHRQ Director Carolyn Clancy and Dr. Mark McClellan to Address Device Executives 2009 MDMA Annu...( WASHINGTON April 14 --...),Health

WASHINGTON, April 14 /PRNewswire-USNewswire/ -- Medical device industry leaders, lawmakers, and government officials will gather for the 2009 Annual Meeting of the Medical Device Manufacturers Association (MDMA) June 1st - 3rd at the Park Hyatt in Washington, D.C.

(Logo: http://www.newscom.com/cgi-bin/prnh/20041004/MDMALOGO)

The MDMA Annual Meeting will bring together executives from innovative entrepreneurial medical technology companies and healthcare's most influential and respected decision makers. Understanding the impact of industry and government trends has never been more important, and we encourage all industry executives to attend. Participants will learn how to respond to current industry challenges and seize available opportunities. The meeting will focus on stimulating new ideas, promoting innovation, and offering solutions in the changing spectrum of medical technology.

Dr. Mark McClellan, with the Brookings Institute and former CMS Administrator, will address healthcare reform at the opening reception; while Carolyn Clancy, the Agency for Healthcare Research and Quality's Director; David Cassak, Windhover Information's Managing Partner; and Andrew Hirshfeld, Acting Deputy Commissioner for Patent Examination Policy at the U.S. Patent and Trademark Office will speak during MDMA's general sessions. Meeting attendees will also hear from panels comprised of seasoned experts from Capitol Hill, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and industry.

In addition to healthcare reform, FDA issues and comparative effectiveness research, this meeting will feature sessions on improving the US patent system, developing a comprehensive com
'/>"/>